bioRxivPharmacology & Toxicology
Discovery and Optimization of Narrow Spectrum Inhibitors of Tousled Like Kinase 2 (TLK2) Using Quantitative Structure Activity Relationships
C. R. M. Asquith, M. P. East, T. Laitinen, C. Alamillo-Ferrer, E. Hartikainen, C. I. Wells, A. D. Axtman, D. H. Drewry, G. J. Tizzard, A. Poso, T. M. Willson, G. L. Johnson
Abstract
The oxindole scaffold has been the center of several kinase drug discovery programs, some of which have led to approved medicines. A series of two oxindole matched pairs from the literature were identified where TLK2 was a potent off-target kinase. The oxindole as long been considered a promiscuous inhibitor template, but across these 4 specific literature oxindoles TLK2 activity was consistent, while the kinome profile was radically different from narrow to broad spectrum coverage. We synthesized a large series of analogues and through quantitative structure-activity relationship (QSAR) analysis, water mapping of the kinase ATP binding sites, small-molecule x-ray structural analysis and kinome profiling, narrow spectrum, sub-family selective, chemical tool compounds were identified to enable elucidation of TLK2 biology.
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Design and analysis of the 4-anilino-quin(az)oline kinase inhibition profiles of GAK/SLK/STK10 using quantitative structure activity relationships
C. R. M. Asquith, T. Laitinen, … A. Poso·bioRxiv·Sep 5, 2019
- Polypharmacology is an enduring and nearly universal property of kinase inhibitors
Caitlin E. Mills, Clemens B. Hug, … Peter Karl Sorger·bioRxiv·Apr 30, 2026
- Synthesis and evaluation of chemical linchpins for highly selective CK2α targeting
Francesco A. Greco, Andreas Krämer, … Stefan Knapp·European Journal of Medicinal ChemistryPeer-reviewed·Jul 14, 2024
- Allosteric inhibition of Aurora-A kinase by a synthetic VNAR nanobody
Selena G Burgess, Arkadiusz Oleksy, … Richard Bayliss·Open BiologyPeer-reviewed·Jul 1, 2016
- Discovery of an IKK2 Site that Allosterically Controls Its Activation
S. J. Hotchkiss, M. C. Mulero, … G. Ghosh·bioRxiv·Jan 27, 2021
- Development of Narrow Spectrum ATP-competitive Kinase Inhibitors as Probes for BIKE and AAK1
Rafael M. Couñago, Alison D. Axtman, … William J. Zuercher·bioRxiv·Mar 2, 2017